Pierre‐François Cartron

5.7k total citations
92 papers, 4.5k citations indexed

About

Pierre‐François Cartron is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Pierre‐François Cartron has authored 92 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 23 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Pierre‐François Cartron's work include Epigenetics and DNA Methylation (35 papers), Cell death mechanisms and regulation (32 papers) and Cancer-related gene regulation (15 papers). Pierre‐François Cartron is often cited by papers focused on Epigenetics and DNA Methylation (35 papers), Cell death mechanisms and regulation (32 papers) and Cancer-related gene regulation (15 papers). Pierre‐François Cartron collaborates with scholars based in France, United States and Czechia. Pierre‐François Cartron's co-authors include François M. Vallette, Éric Hervouet, Lisa Oliver, Philippe Juin, Stéphen Manon, Khaled Méflah, Lisenn Lalier, Paul Peixoto, Mathilde Cheray and Arulraj Nadaradjane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Pierre‐François Cartron

90 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre‐François Cartron France 39 3.4k 810 763 587 411 92 4.5k
Frank Eßmann Germany 40 2.7k 0.8× 685 0.8× 1.1k 1.4× 840 1.4× 459 1.1× 79 4.5k
Michael J. Ausserlechner Austria 33 3.2k 0.9× 663 0.8× 1.1k 1.4× 642 1.1× 404 1.0× 67 4.4k
Jongsun Park South Korea 35 4.0k 1.2× 632 0.8× 591 0.8× 657 1.1× 463 1.1× 126 5.7k
Meiyun Fan United States 34 2.6k 0.8× 1.1k 1.4× 833 1.1× 590 1.0× 270 0.7× 62 3.8k
Stephen Baird Canada 25 3.2k 1.0× 522 0.6× 621 0.8× 595 1.0× 439 1.1× 48 4.1k
Darren D. Browning United States 34 2.5k 0.7× 469 0.6× 666 0.9× 686 1.2× 307 0.7× 72 4.1k
Alessandro Datti Canada 36 2.7k 0.8× 618 0.8× 812 1.1× 328 0.6× 234 0.6× 97 4.1k
Amy Lin United States 21 2.7k 0.8× 514 0.6× 1.1k 1.5× 393 0.7× 476 1.2× 46 4.3k
Emilia Wiecheć Sweden 29 2.1k 0.6× 815 1.0× 1.1k 1.4× 321 0.5× 416 1.0× 46 3.7k
Young Joo Jeon South Korea 36 2.3k 0.7× 1.0k 1.3× 501 0.7× 806 1.4× 396 1.0× 119 3.8k

Countries citing papers authored by Pierre‐François Cartron

Since Specialization
Citations

This map shows the geographic impact of Pierre‐François Cartron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐François Cartron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐François Cartron more than expected).

Fields of papers citing papers by Pierre‐François Cartron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐François Cartron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐François Cartron. The network helps show where Pierre‐François Cartron may publish in the future.

Co-authorship network of co-authors of Pierre‐François Cartron

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐François Cartron. A scholar is included among the top collaborators of Pierre‐François Cartron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐François Cartron. Pierre‐François Cartron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaber, Mohamed, Adam Wilson, Valerie Payne, et al.. (2025). Obesity increases DNA damage in the breast epithelium. Breast Cancer Research. 27(1). 11–11. 3 indexed citations
2.
Nadaradjane, Arulraj, et al.. (2023). Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression. Cancers. 15(12). 3188–3188. 6 indexed citations
3.
Charrier, Céline, Bénédicte Brounais-Le Royer, Pierre‐François Cartron, et al.. (2023). Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells. Environmental Health Perspectives. 131(6). 67007–67007. 4 indexed citations
4.
5.
Sérandour, Aurélien A., Arulraj Nadaradjane, Dominique Heymann, et al.. (2020). N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool. Molecular Therapy — Nucleic Acids. 22. 72–83. 9 indexed citations
6.
Nadaradjane, Arulraj, et al.. (2018). The TET2 Expression Level Correlates with a Short Relapse Time in Glioblastoma Multiforme. HAL (Le Centre pour la Communication Scientifique Directe). 4(2). 1 indexed citations
7.
Vallette, François M., Olivier D. Christophe, Frédéric Lézot, et al.. (2018). Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer. Biochemical Pharmacology. 162. 169–176. 123 indexed citations
8.
Brown, Hannah K., Marta Tellez Gabriel, Pierre‐François Cartron, et al.. (2018). Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?. Drug Discovery Today. 24(3). 763–772. 47 indexed citations
9.
Bagacean, Cristina, Adrian Tempescul, Christelle Le Dantec, et al.. (2017). Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia. Oncotarget. 8(39). 65699–65716. 9 indexed citations
10.
Brenner, Carmen, Judith Luciani, Martin Bizet, et al.. (2016). The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent. Oncotarget. 7(37). 58939–58952. 9 indexed citations
11.
Myrianthopoulos, Vassilios, Pierre‐François Cartron, Zita Liutkevičiūtė, et al.. (2016). Tandem virtual screening targeting the SRA domain of UHRF1 identifies a novel chemical tool modulating DNA methylation. European Journal of Medicinal Chemistry. 114. 390–396. 38 indexed citations
12.
Cheray, Mathilde, et al.. (2014). Histone H3 Phosphorylation in GBM: a New Rational to Guide the Use of Kinase Inhibitors in anti-GBM Therapy. Theranostics. 5(1). 12–22. 36 indexed citations
13.
Cheray, Mathilde, et al.. (2013). Specific inhibition of one DNMT1-including complex influences tumor initiation and progression. Clinical Epigenetics. 5(1). 9–9. 30 indexed citations
14.
Cartron, Pierre‐François, et al.. (2012). Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiforme. Cell Death and Disease. 3(11). e421–e421. 37 indexed citations
15.
Cartron, Pierre‐François, Éric Hervouet, Emilie Debien, et al.. (2012). Folate supplementation limits the tumourigenesis in rodent models of gliomagenesis. European Journal of Cancer. 48(15). 2431–2441. 17 indexed citations
16.
Gauthier, France, Pierre‐François Cartron, Tristan Gallenne, et al.. (2011). Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL.. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
17.
Gautier, Fabien, Yannis Guillemin, Pierre‐François Cartron, et al.. (2010). Bax Activation by Engagement with, Then Release from, the BH3 Binding Site of Bcl-x L. Molecular and Cellular Biology. 31(4). 832–844. 30 indexed citations
18.
Hervouet, Éric, Emilie Debien, L. Campion, et al.. (2009). Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation. Clinical Cancer Research. 15(10). 3519–3529. 59 indexed citations
19.
Gallenne, Tristan, Fabien Gautier, Lisa Oliver, et al.. (2009). Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members. The Journal of Experimental Medicine. 206(5). i8–i8. 8 indexed citations
20.
Cartron, Pierre‐François, Philippe Juin, Lisa Oliver, Khaled Méflah, & François M. Vallette. (2003). Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment. Expert Review of Anticancer Therapy. 3(4). 563–570. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Eßmann Breakdown of academic impact, for papers by Michael J. Ausserlechner Breakdown of academic impact, for papers by Jongsun Park Breakdown of academic impact, for papers by Meiyun Fan Breakdown of academic impact, for papers by Stephen Baird Breakdown of academic impact, for papers by Darren D. Browning Breakdown of academic impact, for papers by Alessandro Datti Breakdown of academic impact, for papers by Amy Lin Breakdown of academic impact, for papers by Emilia Wiecheć Breakdown of academic impact, for papers by Young Joo Jeon
Rankless by CCL
2026